SOUTH SAN FRANCISCO, Calif., April 15 /PRNewswire/ -- diaDexus, Inc. today announced the appointment of Fisher HealthCare as the exclusive customer channel for its new automated PLAC Test for the ...
SOUTH SAN FRANCISCO, Calif. – July 18, 2003 -- diaDexus, Inc., a privately held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company ...
What is the consensus on the new PLAC test (www.plactest.com) that measures lipoprotein-associated phospholipase A 2 (Lp PLA 2) for cardiovascular disease/coronary artery disease risk stratification?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results